Back

Evaluating the impact of the national heart failure implementation program on survival and care optimization in Western Sweden

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Heart failure around the globe Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Carmen Basic

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

6 More presentations in this session

Presentation thumbnail
The burden of heart failure in asian countries from 1990 to 2021: latest data from the 2021 Global Burden of Disease study
Doctor C. Niu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Chagas disease diagnosis and clinical outcomes in patients hospitalized due to heart failure in the United States
Doctor S. Gomez Ochoa (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of cardiovascular-kidney-metabolic burden among heart transplant patients: insights from the swiss transplant cohort study
Mr G. Stauffacher (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Differential impact of gender and socioeconomic indicators on heart failure hospitalisations: A Pan-European population-based time-series analysis
Doctor U. Ojha (Surrey, GB)
Abstract Slides Video
Presentation thumbnail
Changes in the characteristics and treatment of heart failure in Spain (2019-2024): are evidence-based recommendations and clinical practice guidelines being implemented?
Doctor M. Anguita Gamez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure around the globe

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence
thumbnail
Congress Presentation
Registries for improving quality of care
thumbnail
Congress Presentation
Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources